Suxamethonium-Induced Hyperkalemia: A Short Review of Causes and Recommendations for Clinical Applications
Critical Care Research and Practice · 25.02.2021 · 2021 · 1-6
DOI: 10.1155/2021/6613118 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Critical Care Research and Practice, erschienen am 25.02.2021. Verfasst von Henrik Lynge Hovgaard und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Intensive Care, Regionshospitalet Viborg, Heibergs Alle 5A, Viborg 8800, Denmark. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
After the introduction of suxamethonium in 1953, cases of cardiac arrest during induction of anesthesia were recorded. In the following years, hyperkalemia was identified as the cause, and the connection to acetylcholine receptor modulation as the underlying molecular mechanism was made. Activation of the acetylcholine receptor with suxamethonium, acetylcholine, or choline causes an efflux of potassium to the extracellular space. However, certain pathological conditions cause acetylcholine receptor proliferation and the emergence of immature receptors capable of a larger potassium efflux to the bloodstream. These pathologic conditions include upper and lower neuron injuries, major burns, trauma, immobility, muscle tumors, muscular dystrophy, and prolonged critical illness. The latter is more important and relevant than ever due to the increasing number of COVID-19 patients requiring prolonged respiratory support and consequent immobilization. Suxamethonium can be used safely in the vast majority of patients. Still, reports of lethal hyperkalemic responses to suxamethonium continue to emerge. This review serves as a reminder of the pathophysiology behind extensive potassium release. Proficiency in the use of suxamethonium includes identification of patients at risk, and selection of an alternative neuromuscular blocking agent is imperative.
Autor:innen und Institutionen
- Department of Anaesthesiology and Intensive Care, Regionshospitalet Viborg, Heibergs Alle 5A, Viborg 8800, Denmark.
- Department of Internal Medicine, Randers Regional Hospital, Skovlyvej 15, Randers 8930, Denmark.
- Department of Anaesthesiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus 8200, Denmark.
- Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 82, Aarhus 8200, Denmark.
ORCID-Profile: Henrik Lynge Hovgaard
Zitieren
APA
Hovgaard, H. L., & Juhl-Olsen, P. (2021). Suxamethonium-Induced Hyperkalemia: A Short Review of Causes and Recommendations for Clinical Applications. Critical Care Research and Practice, 2021, 1-6. https://doi.org/10.1155/2021/6613118
Vancouver
Hovgaard HL, Juhl-Olsen P. Suxamethonium-Induced Hyperkalemia: A Short Review of Causes and Recommendations for Clinical Applications. Critical Care Research and Practice. 2021;2021:1-6. doi:10.1155/2021/6613118
BibTeX
@article{Hovgaard2021,
author = {Hovgaard, Henrik Lynge and Juhl-Olsen, Peter},
title = {Suxamethonium-Induced Hyperkalemia: A Short Review of Causes and Recommendations for Clinical Applications},
journal = {Critical Care Research and Practice},
year = {2021},
volume = {2021},
pages = {1--6},
doi = {10.1155/2021/6613118}
}
EUVIMED